Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces its presence at J.P. Morgan 34th annual healthcare conference taking place from January 12 to January 15, 2015, in San Francisco, California (USA).
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2015/01/QGC_PR_JPMORGAN-HEALTH-20150112_UK.pdf” target=”_blank” title=”Download press release” size=”small” color=”red”]
